We recently published a list of 10 Firms End Friday Strong; 3 Reach All-Time Highs. In this article, we are going to take a ...

The fifth-largest healthcare stock in the S&P 500 Index ($SPX) is proving that just because a stock is down 30%, it’s not a ...

Value stocks aren't typically the most exciting investments, but they can often provide steady capital gains without causing investors to lose any sleep during periods of market volatility.

The interleukin-2 (IL-2) therapies market in the USA is poised for major growth, projected to reach $4 billion by 2034, ...

Within that group, biotechnology giant Amgen (NASDAQ: AMGN) has been the best-performing stock in 2025, returning an ...

3月28日，中国国家药监局药品审评中心（CDE）官网最新公示，默沙东 ...

2025年3月27日，制药公司默沙东（MRK）成交额为10.84亿美元，在当日美股中排第54名，成交额较昨日减少11.13%，当日成交量为1235.73万。 默沙东（MRK）于2025年3月27日跌0.58%，报87.6美元，该股过去5个交易日跌7.53%，整个3月跌5.04%，年初至今跌11.94%，过去52周跌33.51%。

We recently published a list of 10 Low Volatility Stocks to Buy According to Billionaire Ken Fisher. In this article, we are ...

Merck signed a licensing agreement for a heart disease drug with Jiangsu Hengrui Pharmaceuticals worth up to $2 billion.

Last year, the total production of maple syrup in Vermont came to about 3.1 million gallons, about 53 percent of the entire ...

Investing.com -- According to Reuters, several drugmakers have reportedly begun accelerating shipments of medicines to the United States in response to potential tariff threats from President Donald ...

Merck (NYSE: MRK) is a top healthcare company with one of the best drugs ever made in its portfolio: Keytruda. During the ...